Bolt Biotherapeutics, Inc. (BOLT) vs NeuroSense Therapeutics Ltd. (NRSN)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and NeuroSense Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.38HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
NRSN
NeuroSense Therapeutics Ltd.
$3.97HealthcareDelayed quote: Oct 6, 2026, 11:21 AM EDT
Total return — BOLT vs NRSN
growth of $100 · dividends reinvested · last 5yBOLT -96.3% (-48.3%/yr)NRSN -95.0% (-45.1%/yr)NRSN compounded faster over this window
BOLT NRSN
BOLT vs NRSN: by the numbers
- •NRSN is the larger company ($7M vs $6M market cap).
- •Both run net losses; NRSN's is the smaller (0.00% vs -611.47% net margin).
Metrics side by side
Valuation
| Metric | BOLT | NRSN |
|---|---|---|
| P/S ratio | 1.38 | N/A |
| P/B ratio | 0.51 | N/A |
Profitability
| Metric | BOLT | NRSN |
|---|---|---|
| Gross margin | 80.62% | 0.00% |
| Operating margin | -450.07% | 0.00% |
| Net margin | -611.47% | 0.00% |
| ROE | -227.37% | N/A |
| ROIC | -90.17% | N/A |
Growth (annualized)
| Metric | BOLT | NRSN |
|---|---|---|
| Total return CAGR (5Y) | -57.61% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.